ed silverman (@edsilverman) 's Twitter Profile
ed silverman

@edsilverman

Pharmalot columnist and senior writer at @STATnews.. former WSJer.. proud dad; likes music, dogs and taking naps

ID: 17445167

linkhttp://www.statnews.com/pharmalot/ calendar_today17-11-2008 17:00:17

282 Tweet

5,5K Followers

144 Following

ed silverman (@edsilverman) 's Twitter Profile Photo

Eli Lilly is making some dramatic cuts to list prices of its insulin products.. Matthew Herper & I spoke to CEO David Ricks, and also to several experts and a patient advocate who were hopeful but a bit skeptical. statnews.com/pharmalot/2023… #pharma #diabetes #insulin $LLY $SNY $NVO

ed silverman (@edsilverman) 's Twitter Profile Photo

European Union drug pricing proposal for the pandemic treaty generates pushback.. statnews.com/pharmalot/2023… #pharma #pandemic #WHO

ed silverman (@edsilverman) 's Twitter Profile Photo

‘True disruption’: Mark Cuban’s company will sell brand-name diabetes medicines from J&J.. statnews.com/pharmalot/2023… #pharma #diabetes $JNJ

ed silverman (@edsilverman) 's Twitter Profile Photo

Gilead defeats federal government in closely watched battle over patents for HIV prevention pills.. statnews.com/pharmalot/2023… #pharma #patents #HIV #AIDS #CDC #HHS $GILD

ed silverman (@edsilverman) 's Twitter Profile Photo

SEC charges former Pfizer statistician with insider trading over Paxlovid clinical trial results.. statnews.com/pharmalot/2023… #pharma #SEC #insidertrading #Paxlovid $PFE

ed silverman (@edsilverman) 's Twitter Profile Photo

Drug wholesaler owner indicted for alleged role in diverting Gilead and J&J HIV medicines.. read the indictment here.. statnews.com/pharmalot/2023… #pharma #HIV #counterfeit $GILD $JNJ

ed silverman (@edsilverman) 's Twitter Profile Photo

J&J agrees not to enforce patents on a key tuberculosis drug in dozens of poor countries.. statnews.com/pharmalot/2023… #pharma #patents #TB #tuberculosis #medicine $JNJ

ed silverman (@edsilverman) 's Twitter Profile Photo

Colombia set to issue a compulsory license for an HIV medicine sold by GSK’s ViiV.. statnews.com/pharmalot/2023… #pharma #patent #HIV #AIDS #Colombia $GSK $PFE

ed silverman (@edsilverman) 's Twitter Profile Photo

Was Amgen less than forthcoming about FDA’s concerns on its cancer drug?.. my latest column.. feedback, suggestions, criticism are welcome.. statnews.com/2023/10/04/amg…… #pharma #biotech #cancer #FDA #transparency #clinicaltrials $AMGN

ed silverman (@edsilverman) 's Twitter Profile Photo

‘We’ve exhausted all avenues’: A small biotech may give up on its ultra-rare disease drug over frustration with FDA.. statnews.com/pharmalot/2023… #pharma #biotech #FDA #raredisease #orphandrug

ed silverman (@edsilverman) 's Twitter Profile Photo

Patent thickets and terminal disclaimers: How pharma blocks biosimilars from the marketplace.. statnews.com/pharmalot/2023… #pharma #biotech #biosimilar #patents

ed silverman (@edsilverman) 's Twitter Profile Photo

When it comes to policing pharma, the FTC says it’s on ‘an incredible winning streak’.. statnews.com/pharmalot/2024… #pharma #FTC #antitrust #monopoly #Biden #rebates #patents #mergers $CVS $AMGN $UNH $CI $GSK $AZN $SNY

ed silverman (@edsilverman) 's Twitter Profile Photo

Pricey sickle cell treatments raise daunting new challenges for Medicaid programs.. statnews.com/pharmalot/2024… #pharma #sicklecell #Medicaid $VRTX $CRSP $BLUE

ed silverman (@edsilverman) 's Twitter Profile Photo

CMS will use outcomes-based agreements in bid to help Medicaid pay for sickle cell gene therapies.. statnews.com/pharmalot/2024… #pharma #Medicaid #CMS #medicines #sicklecell $VRTX $CRSP $BLUE

ed silverman (@edsilverman) 's Twitter Profile Photo

After nearly 30 years covering pharma, you might think I know it all. Here's your chance to find out... you can Ask Me Anything on Thursday, Feb. 15 at 1 pm ET.. click on this STAT+ Connect link to sign up... connect.statnews.com/landing

After nearly 30 years covering pharma, you might  think I know it all. Here's your chance to find out... you can Ask Me Anything on Thursday, Feb. 15 at 1 pm ET..  click on this STAT+ Connect  link to sign up...

connect.statnews.com/landing
ed silverman (@edsilverman) 's Twitter Profile Photo

“The messages are filled with misinformation that is hard to set straight because it is such a complicated topic and patients are made to feel like their lives are at stake" statnews.com/pharmalot/2024… #pharma #RareDiseases #medicines #drugs #Colorado #Enbrel $AMGN $VRTX

ed silverman (@edsilverman) 's Twitter Profile Photo

“Colombia is planting a flag for global health equity,” said Peter Maybarduk of Public Citizen. “This will inspire new challenges to patent barriers and improve treatment access, towards an AIDS-free generation." statnews.com/pharmalot/2024… #patents #medicines #Colombia #HIV $GSK

ed silverman (@edsilverman) 's Twitter Profile Photo

““The whole purpose of biosimilars was to introduce competition into the marketplace," said study author Ben Rome. "...The fact that it’s so hard to find savings consistently is disappointing." statnews.com/pharmalot/2024… #pharma #biotech #biologics #biosimilars #medicines

ed silverman (@edsilverman) 's Twitter Profile Photo

Student group that ranked med schools over industry conflicts votes to accept pharma funding.. statnews.com/pharmalot/2024… #pharma #medicine #MedicalEducation #medschool #conflicts

ed silverman (@edsilverman) 's Twitter Profile Photo

FDA scolds Merz over ‘misleading’ Instagram posts featuring interior designer Nate Berkus.. statnews.com/pharmalot/2024…… #pharma #FDA #botox #wrinkles #Instagram